NEW YORK, April 4 – Cambridge Antibody Technology of Melbourn, UK, said Wednesday it had filed a request with the US Securities and Exchange Commission to list American Depositary Receipts on the Nasdaq.

Rowena Gardner, head of corporate communications at CAT, said the company, which trades on the London Stock Exchange, decided to list ADRs on the Nasdaq in order to better service investors.

“Forty percent of our investors are in the states,” Gardner said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.